BAMLANIVIMAB
UNII 45I6OFJ8QH

Substance Identification & Data

This profile provides standardized clinical and technical data for Bamlanivimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 45I6OFJ8QH.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2423943-37-5 and the RxNorm Concept ID (RxCUI) 2463114. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

45I6OFJ8QH

CAS Registry Number

2423943-37-5

RxNorm Concept ID

2463114

Detailed Substance Profile

Preferred Name

BAMLANIVIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C173742

National Cancer Institute reference terminology for clinical and research data.

INN ID

11876

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

JK-04

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Bamlanivimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BAMLANIVIMAB

Common Names & Synonyms

BAMLANIVIMAB [INN]

BAMLANIVIMAB [USAN]

BAMLANIVIMAB [WHO-DD]

IMMUNOGLOBULIN G1, ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN) (HUMAN MONOCLONAL LY3819253 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LY3819253 .KAPPA.-CHAIN, DIMER